WE MAKE AQUACULTURE PROGRESS
PHARMAQ part of Zoetis hires Dagfinn Strømme as General Manager PHARMAQ Fishteq
[June 13, 2019] PHARMAQ part of Zoetis is pleased to announce its recent hire of Dagfinn Strømme PHARMAQ as General Manager of PHARMAQ Fishteq from June 1, 2019.
Dagfinn Strømme comes to PHARMAQ with extensive experience from management and sales positions in equipment for laboratory and biotechnology activities. He has worked for large companies such as VWR International, QIAGEN, and Nordiag. Strømme has a Bachelor in Immunology and Microbiology from the University of Strathclyde and Sør-Trøndelag University College.
Strømme will be a part of PHARMAQ management team report directly to Morten Nordstad, President PHARMAQ part of Zoetis.
“We are very happy to have Dagfinn on our team heading PHARMAQ's vaccination equipment and service business. He brings valuable management experience and commercial expertise from the industry and will be an essential addition to the management team. This strengthens our goal of being a complete supplier to the global aquaculture industry,” says Morten Nordstad.
“I look forward to support the aquaculture industry now, after a period of delivering to the laboratory side of the industry. PHARMAQ is an exciting company, and I hope to be able to contribute to further growth for the company through strategic focus on vaccination services and automation,” says Dagfinn Strømme.
“We warmly welcome Dagfinn to PHARMAQ and look forward to see PHARMAQ Fishteq deliver new, innovative products and services to our customers, says Nordstad.
For more information please contact:
President PHARMAQ a business of Zoetis
Mobile: +47 907 52 853
PHARMAQ is the global leader in fish health and vaccines, dedicated to support sustainable growth in the aquaculture industry. PHARMAQ is part of Zoetis, the world leader in animal health. Our innovative fish health solutions include PHARMAQ fish vaccines and therapeutics, PHARMAQ Fishteq vaccination machinery, and PHARMAQ Analytiq research and analysis. PHARMAQ’s research and production facilities are based in Norway, with global operations in commercial fish farming markets. PHARMAQ has 300 employees. We invest in our people and offer opportunities to make a difference in a growing aquaculture industry. To learn more, visit PHARMAQ.com and Zoetis.com.
Did you know...
Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.
Pharmaq produserer vaksiner til 70 prosent av verdens laks
Europe Fish Vaccine Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025
Pharmaq recibe autorización para comercialización de nueva vacuna
Farmed Salmon is a Core Component of Healthy, Sustainable Diets
Har fått markedsføringstillatelse til ny vaksine - Kyst.no
Global Deltamethrin Market Analysis, Revenue, Share, Size, Developments, Feasibility Check
I denne bygda produserer de vaksiner til 70 prosent av verdens laks
FDA awards grants to help fund MUMS research
How Impact of Covid-19 on Single Drum Friability Testers market Development is Changing Business Needs?
Veterinary Vaccines Market : Facts, Figures and Analytical Insights 2020